He continues to provide scientific advice to Keyron for no remuneration
Over 68 weeks, with a starting dose of 2 mg escalated every 4 weeks: 9 mg dose: 26.4% average body weight reduction (29.1 kg / 64.2 lbs) 12 mg dose: 28.7% average body weight reduction (32.3 kg / 71.2 lbs) Placebo: 2.1% average body weight reduction The milestone achievements tell an even more compelling story
Egecioglu E, Engel J, Jerlhag E, Egecioglu E, Engel JA, Jerlhag E
Scheduled to launch on July 1, this initiative aims to offer these medications for a $50 monthly co-payment
It helps to: Improve glucose and fat metabolism Enhance energy and endurance Increase insulin sensitivity Promote new mitochondrial formation (biogenesis) Think of MOTS-C as a software upgrade for your cells that reprograms your metabolism for optimal energy and repair
This value gets split among manufacturers, third-party payers like Medicare, and patients, depending on how much of the social value accrues to each